Table 1.
Clinical characteristics and laboratory data of HD patients (n = 41) and healthy subjects (n = 23)
| Characteristic | HD patients (n = 41) | Healthy subjects (n = 23) | P |
|---|---|---|---|
| Age (years) | 50.7 ± 14.5 | 45.3 ± 8.9 | 0.068 |
| Sex | |||
| Males | 25 (61%) | 14 (60.9%) | 0.993 |
| Females | 16 (39%) | 9 (39.1%) | |
| Body weight (Kg) | 73 (63–78.8) | 77 (70–80) | 0.266 |
| Occupation | |||
| Not working | 22 (53.7) | 18 (78.3) | 0.051 |
| Working | 19 (46.3) | 5 (21.7) | |
| Marital status | |||
| Single | 9 (22) | 10 (43.5) | 0.053 |
| Married | 32 (78) | 13 (56.5) | |
| Duration of HD (years) | 4 (2–6) | – | – |
| Vascular access | |||
| Right side | 8 (19.5) | – | – |
| Left side | 33 (80.5) | – | |
| Hemoglobin (g/dL) | 9.9 (9.2–10.9) | N/A | – |
| Cholesterol (mg/dL) | 110 (93–130.5) | N/A | – |
| Triglycerides (mg/dL) | 73 (63–10.4.5) | N/A | – |
| Calcium (mg/dL) | 8.5 (7–9.5) | N/A | – |
| Phosphorus (mg/dL) | 6 (3.6–8.5) | N/A | – |
| PTH (pg/mL) | 518 (207–1090.5) | N/A | – |
| Uric acid (mg/dl) | 6.4 (5.4–7) | N/A | – |
Quantitative variables are expressed as mean ± standard deviation for normally distributed data and median (25th percentile – 75th percentile) for non-normally distributed data. Qualitative variables are expressed as number (%)
PTH Parathyroid hormone